126 related articles for article (PubMed ID: 37224650)
21. All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-β1/Smad3 signaling pathway in rats.
Song X; Liu W; Xie S; Wang M; Cao G; Mao C; Lv C
Lab Invest; 2013 Nov; 93(11):1219-31. PubMed ID: 24042439
[TBL] [Abstract][Full Text] [Related]
22. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
[TBL] [Abstract][Full Text] [Related]
23. Baicalein attenuates bleomycin-induced lung fibroblast senescence and lung fibrosis through restoration of Sirt3 expression.
Ji-Hong Y; Yu M; Ling-Hong Y; Jing-Jing G; Ling-Li X; Lv W; Yong-Mei J
Pharm Biol; 2023 Dec; 61(1):288-297. PubMed ID: 36815239
[TBL] [Abstract][Full Text] [Related]
24. Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway.
Li G; Shen C; Wei D; Yang X; Jiang C; Yang X; Mao W; Zou J; Tan J; Chen J
Lung; 2023 Apr; 201(2):235-242. PubMed ID: 36823409
[TBL] [Abstract][Full Text] [Related]
25. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways.
Lv Q; Wang J; Xu C; Huang X; Ruan Z; Dai Y
Mol Med; 2020 May; 26(1):49. PubMed ID: 32448163
[TBL] [Abstract][Full Text] [Related]
26. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo.
Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW
Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129
[TBL] [Abstract][Full Text] [Related]
27. Costunolide inhibits pulmonary fibrosis via regulating NF-kB and TGF-β
Liu B; Rong Y; Sun D; Li W; Chen H; Cao B; Wang T
Biochem Biophys Res Commun; 2019 Mar; 510(2):329-333. PubMed ID: 30709583
[TBL] [Abstract][Full Text] [Related]
28. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
29. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
[TBL] [Abstract][Full Text] [Related]
30. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
Duan FF; Barron G; Meliton A; Mutlu GM; Dulin NO; Schuger L
Am J Respir Cell Mol Biol; 2019 Feb; 60(2):221-231. PubMed ID: 30230348
[TBL] [Abstract][Full Text] [Related]
31. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
32. Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-β1/Smad2 pathways and overexpression of NOX4.
Zhang D; Liu B; Cao B; Wei F; Yu X; Li GF; Chen H; Wei LQ; Wang PL
Int Immunopharmacol; 2017 Jul; 48():67-75. PubMed ID: 28476015
[TBL] [Abstract][Full Text] [Related]
33. Peptide PD29 treats bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β/smad signaling pathway.
Sun Q; Hu J; Yu P; Zhu Z; Yu R; Ge C; Li C; Wu G; Lin B; Liu G; Liu M; Bian H; Xu H; Jia S
Exp Lung Res; 2019; 45(5-6):123-134. PubMed ID: 31210057
[TBL] [Abstract][Full Text] [Related]
34. Verbascoside and isoverbascoside ameliorate transforming growth factor β1-induced collagen expression by lung fibroblasts through Smad/non-Smad signaling pathways.
Chen CY; Tung HY; Tseng YF; Huang JS; Shi LS; Ye YL
Life Sci; 2022 Nov; 308():120950. PubMed ID: 36100079
[TBL] [Abstract][Full Text] [Related]
35. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
[TBL] [Abstract][Full Text] [Related]
36. Cereblon contributes to the development of pulmonary fibrosis via inactivation of adenosine monophosphate-activated protein kinase α1.
Kang HJ; Lee KJ; Woo J; Kim J; Kim YK; Lee CH; Yoo CG; Lee KH
Exp Mol Med; 2021 May; 53(5):885-893. PubMed ID: 34002012
[TBL] [Abstract][Full Text] [Related]
37. Silencing lncRNA Snhg6 mitigates bleomycin-induced pulmonary fibrosis in mice via miR-26a-5p/TGF-β1-smads axis.
Deng W; Zhang Y; Fang P; Shi H; Yang S
Environ Toxicol; 2022 Oct; 37(10):2375-2387. PubMed ID: 35785413
[TBL] [Abstract][Full Text] [Related]
38. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation.
Kim S; Lim JH; Woo CH
Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2.
Chen X; Shi C; Meng X; Zhang K; Li X; Wang C; Xiang Z; Hu K; Han X
Exp Mol Pathol; 2016 Aug; 101(1):22-30. PubMed ID: 27112840
[TBL] [Abstract][Full Text] [Related]
40. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.
Venkatesan N; Tsuchiya K; Kolb M; Farkas L; Bourhim M; Ouzzine M; Ludwig MS
Am J Respir Cell Mol Biol; 2014 Mar; 50(3):583-94. PubMed ID: 24127863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
